Search

Day One Biopharmaceuticals Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-21M

Sales

54M

Profit margin

-39.611

Employees

178

EBITDA

-26M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

-3.62% downside

Market Stats

By TradingEconomics

Market Cap

2.2B

Previous open

0

Previous close

0

Day One Biopharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

13 Oct 2026, 23:51 UTC

News

Etsy Inc shares are trading lower in after-market hours despite Payoneer's renewal of its partnership through 2029 to support international sellers.

13 Oct 2026, 23:51 UTC

News

DraftKings Inc shares are trading lower in after-market hours as the FTC launches a preliminary inquiry into potential deceptive practices in the sports betting industry.

13 Oct 2026, 23:51 UTC

News

UBS maintains a Buy rating on Apollo Global Management while lowering its price target to $163, citing a 17.36% average annual return over 15 years.

13 Oct 2026, 23:41 UTC

News

Citigroup maintains a Neutral rating on Phillips 66 and raises its price target to $297, reflecting ongoing confidence in the company's performance.

13 Oct 2026, 23:41 UTC

News

Shares of Wayfair Inc are trading lower in after-market hours following the announcement of an expanded partnership with Klarna Group, offering 0% APR financing.

13 Oct 2026, 23:41 UTC

News

Cheniere Energy Inc shares declined modestly in after-market trading amid rising LNG prices in Asia and concerns over low gas storage levels in Europe.

13 Oct 2026, 23:36 UTC

News

L3Harris Technologies partners with Divergent Technologies to enhance production capabilities for its Wolf Pack munitions, utilizing additive manufacturing for battlefield adaptability.

13 Oct 2026, 23:36 UTC

News

PG&E Corp prepares for potential Public Safety Power Shutoffs affecting 70k customers across 29 counties due to high winds and dry conditions.

13 Oct 2026, 23:31 UTC

News

B&G Foods Inc sells its B&M and Joan of Arc brands to McCall Farms, aiming to use proceeds for long-term debt repayment.

13 Oct 2026, 23:26 UTC

News
Correlated Moves

ServiceNow is reportedly in early discussions to acquire AI startup Decagon, which was valued at $4.5 billion earlier this year.

13 Oct 2026, 23:26 UTC

News

Leidos Holdings awarded a $317.99 million contract by the Defense Health Agency for MHS Genesis system reintegration and software services, running from 2026 to 2028.

13 Oct 2026, 23:16 UTC

News

Citigroup maintains Buy rating on Tractor Supply Co and raises price target to $38, providing a bullish outlook for the company.

13 Oct 2026, 23:16 UTC

News
Correlated Moves

Welltower to sell 30 leased communities to Brookdale Senior Living for $290 million, reducing Brookdale's annual cash rent payments by about $17.8 million.

13 Oct 2026, 23:16 UTC

News

A securities class action lawsuit has been filed against DICK'S Sporting Goods, alleging misleading statements about financial performance and inventory management.

13 Oct 2026, 23:11 UTC

News
Social Media

Microsoft directs senior leaders to cut Azure costs by 20%, amid ongoing restructuring, according to a report from The Information.

13 Oct 2026, 23:11 UTC

News
Correlated Moves

The USD/SEK is modestly lower following the NFIB Small Business Optimism Index for September, which came in at 97.9, below the forecast of 98.1.

13 Oct 2026, 23:06 UTC

News

Cirrus Logic withdraws its acquisition proposals for Synaptics, confirming its role as "Party A" in the pending merger with ON Semiconductor.

13 Oct 2026, 23:06 UTC

News

Interactive Brokers Group Inc shares are declining in after-market trading, despite a 35% year-over-year increase in client accounts and the launch of Ethereum staking services.

13 Oct 2026, 23:06 UTC

News

NetApp Inc shares declined during after-market hours on Tuesday, though they remained above their lowest point reached after the regular session ended.

13 Oct 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are little changed in after-market trading, having retraced from earlier gains despite Citigroup's higher performance following its earnings results.

13 Oct 2026, 23:06 UTC

News

UBS reaffirms Buy rating on KKR & Co Inc, lowering price target to $122; KKR Fs Income Trust secures up to $250M loan agreement.

13 Oct 2026, 23:02 UTC

Macro News
News

Bitcoin advances as a UK High Court ruling permits retention of 61k seized BTC, while Russia's Sberbank is authorized to facilitate Bitcoin transactions.

13 Oct 2026, 23:01 UTC

News

Cisco Systems Inc shares declined in after-market trading, with a put/call ratio of 0.66 indicating a moderately bearish outlook among traders.

13 Oct 2026, 23:01 UTC

News

Rivian Automotive appoints Doug Field as president of Mind Robotics, focusing on AI and robotics in manufacturing, with the spinoff securing over $1 billion for development.

13 Oct 2026, 23:01 UTC

News

Quarterly cash dividend raised to $0.26; 650k shares repurchased.

13 Oct 2026, 23:01 UTC

News

USD/ZAR is trading modestly lower, influenced by the U.S. NFIB Small Business Optimism index, which came in at 97.9, below the forecast of 98.1.

13 Oct 2026, 23:01 UTC

News
Correlated Moves

USD/NOK is modestly lower following the release of U.S. NFIB small business optimism data for September, which came in at 97.9, below expectations.

13 Oct 2026, 23:01 UTC

News

Energy Fuels Inc filed a prospectus to offer common shares of up to $500 million to raise capital.

13 Oct 2026, 23:01 UTC

News
Social Media

GameStop shares advanced after CEO Ryan Cohen disclosed the purchase of 844.13k shares, increasing his stake to approximately 9.1%, totaling over $22 million.

13 Oct 2026, 23:01 UTC

Event
Social Media
News

AZZ Inc. reported fiscal Q2 sales of $486.9 million and adjusted EPS of $2.00, raising its fiscal year 2027 guidance for EPS and sales.

Peer Comparison

Price change

Day One Biopharmaceuticals Inc Forecast

Price Target

By TipRanks

-3.62% downside

12 Months Forecast

Average 20.75 USD  -3.62%

High 21.5 USD

Low 17 USD

Based on 7 Wall Street analysts offering 12 month price targets forDay One Biopharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

7 ratings

1

Buy

6

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
help-icon Live chat